During the past decade, St. Marianna University School of Medicine Hospital conducted 83 clinical trials. In the 10-year time frame, 83 clinical trials started and 27 clinical trials were completed, i.e. on average, 32.5% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 22 clinical trials were completed. i.e. 45.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Marianna University School of Medicine Hospital" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Janssen Research & Development, LLC" with 8 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Amgen" with 5 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Marianna University School of Medicine Hospital" #1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Boehringer Ingelheim" with 2 trials as a collaborator, "Kitasato University" with 2 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "St. Marianna University School of Medicine Hospital" are "Gastric Cancer" (6 trials), "Heart Failure" (5 trials), "Hemophilia A" (5 trials), "Urinary Bladder Neoplasms" (4 trials) and "Breast Neoplasms" (3 trials). Many other conditions were trialed in "St. Marianna University School of Medicine Hospital" in a lesser frequency.

Most popular intervention types in "St. Marianna University School of Medicine Hospital" are "Drug" (80 trials), "Biological" (10 trials), "Other" (10 trials), "Device" (7 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Irinotecan" (4 trials), "Nipocalimab" (3 trials), "S-1" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Marianna University School of Medicine Hospital" are 92 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "St. Marianna University School of Medicine Hospital". 1 are not yet recruiting, 34 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in St. Marianna University School of Medicine Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in St. Marianna University School of Medicine Hospital, 8 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".